Who we are

Imperial College London is consistently ranked amongst the top 10 Universities in the world. It is one of the largest Universities in Europe, and it is truly international, with 17,000 students from 125 countries, and 8,000 staff, 50% from outside the UK. Imperial College London focuses on 4 main disciplines, science, engineering, medicine, and business. The Imperial College London Academic Health Sciences Centre brings together interdisciplinary research efforts linking clinical medicine with science, technology and engineering focused on health problems. Imperial College London has world renowned expertise in the application of omics technologies to health; and in computational biology, linking mathematics, statistics and computer science. The core concepts developed in the DIAMONDS proposal arise from linking the molecular and computational strengths within the College. Imperial College London also has an international reputation for leadership in clinical research, observational studies and clinical trials, and project management. The DIAMONDS project links the research excellence in medicine, computational biology and molecular biology within Imperial College London.

Our role in DIAMONDS

Imperial College London is the Coordinating Centre for DIAMONDS. Between groups working in the Department of Infectious Disease (led by Prof Mike Levin), the Department of Electronic Engineering (led by Dr Pantelis Georgiou), and Research Impact Management Office (led by Dr Marta Archanco), Imperial College London will undertake:

  • Coordination and project management. Imperial College London is the Lead institution and Prof Levin is Coordinator
  • Clinical recruitment, ethical oversight, patient phenotyping and pilot demonstration. Imperial College London is co-lead for work package (WP) 1. Dr Jethro Herberg at Imperial College London will lead the recruitment and phenotyping of patients, with Dr Aubrey Cunnington coordinating the clinical activities of the non-EU sites (The Gambia, Nepal, Taiwan). Imperial College London will contribute to data collection for the societal and economic analysis (WP7) and is a lead site for the Pilot Demonstration (WP8) and for ethical oversight (WP12).
  • Imperial College London is co-leading the transcriptomics work package in DIAMONDS.
  • Bioinformatics, data management and modelling. Dr Myrsini Kaforou at Imperial College London is lead for this work package.
  • Engineering and product development. Dr Pantelis Georgiou is lead for development of a new point-of-care PMSD detection device based on microchip technology.
  • Support of all work packages. As the coordinating centre, and lead for bioinformatics, data management and modelling, Imperial College London will play a supporting and coordinating role in all work packages to ensure smooth and coordinated running of the project. Dr Victoria Wright is Scientific Project Manager.

Our team

To learn more about our team and research areas, please use the below links:

The Section of Paediatric Infectious Disease

The Section of Infection Technology

The Research Impact Management Office

See all Partners
EU Flag

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848196